ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/09 | 1,660 | 1,695 | 1,653 | 1,680 | +23 | +1.4% | 78,200 |
| 2024/07/08 | 1,661 | 1,667 | 1,646 | 1,657 | -4 | -0.2% | 39,700 |
| 2024/07/05 | 1,650 | 1,666 | 1,643 | 1,661 | +23 | +1.4% | 72,600 |
| 2024/07/04 | 1,649 | 1,656 | 1,636 | 1,638 | +2 | +0.1% | 65,800 |
| 2024/07/03 | 1,612 | 1,640 | 1,612 | 1,636 | +18 | +1.1% | 98,500 |
| 2024/07/02 | 1,619 | 1,624 | 1,605 | 1,618 | -3 | -0.2% | 74,200 |
| 2024/07/01 | 1,620 | 1,635 | 1,603 | 1,621 | -1 | -0.1% | 103,600 |
| 2024/06/28 | 1,675 | 1,681 | 1,622 | 1,622 | -59 | -3.5% | 166,700 |
| 2024/06/27 | 1,655 | 1,696 | 1,640 | 1,681 | -1,729 | -50.7% | 180,800 |
| 2024/06/26 | 3,440 | 3,455 | 3,405 | 3,410 | +20 | +0.6% | 51,300 |
| 2024/06/25 | 3,390 | 3,435 | 3,360 | 3,390 | +10 | +0.3% | 55,300 |
| 2024/06/24 | 3,355 | 3,380 | 3,335 | 3,380 | +50 | +1.5% | 31,600 |
| 2024/06/21 | 3,380 | 3,400 | 3,330 | 3,330 | -70 | -2.1% | 62,900 |
| 2024/06/20 | 3,380 | 3,400 | 3,355 | 3,400 | +25 | +0.7% | 29,400 |
| 2024/06/19 | 3,445 | 3,445 | 3,370 | 3,375 | -35 | -1% | 30,400 |
| 2024/06/18 | 3,405 | 3,435 | 3,385 | 3,410 | +5 | +0.1% | 18,100 |
| 2024/06/17 | 3,450 | 3,450 | 3,385 | 3,405 | -45 | -1.3% | 36,200 |
| 2024/06/14 | 3,470 | 3,470 | 3,430 | 3,450 | -5 | -0.1% | 9,900 |
| 2024/06/13 | 3,485 | 3,485 | 3,430 | 3,455 | -30 | -0.9% | 31,800 |
| 2024/06/12 | 3,515 | 3,520 | 3,480 | 3,485 | -15 | -0.4% | 24,400 |
| 2024/06/11 | 3,515 | 3,540 | 3,500 | 3,500 | -15 | -0.4% | 23,100 |
| 2024/06/10 | 3,515 | 3,520 | 3,500 | 3,515 | ±0 | ±0% | 24,500 |
| 2024/06/07 | 3,515 | 3,515 | 3,485 | 3,515 | ±0 | ±0% | 21,300 |
| 2024/06/06 | 3,485 | 3,515 | 3,470 | 3,515 | +40 | +1.2% | 38,400 |
| 2024/06/05 | 3,480 | 3,490 | 3,465 | 3,475 | ±0 | ±0% | 24,200 |
| 2024/06/04 | 3,480 | 3,490 | 3,460 | 3,475 | ±0 | ±0% | 26,000 |
| 2024/06/03 | 3,465 | 3,485 | 3,440 | 3,475 | +35 | +1% | 37,100 |
| 2024/05/31 | 3,405 | 3,460 | 3,405 | 3,440 | +20 | +0.6% | 38,700 |
| 2024/05/30 | 3,415 | 3,425 | 3,380 | 3,420 | -5 | -0.1% | 33,800 |
| 2024/05/29 | 3,435 | 3,435 | 3,410 | 3,425 | -10 | -0.3% | 12,900 |
| 2024/05/28 | 3,400 | 3,440 | 3,400 | 3,435 | +15 | +0.4% | 18,600 |
| 2024/05/27 | 3,400 | 3,430 | 3,390 | 3,420 | +30 | +0.9% | 13,900 |
| 2024/05/24 | 3,385 | 3,415 | 3,375 | 3,390 | -20 | -0.6% | 12,100 |
| 2024/05/23 | 3,420 | 3,430 | 3,390 | 3,410 | +20 | +0.6% | 20,100 |
| 2024/05/22 | 3,440 | 3,440 | 3,380 | 3,390 | -30 | -0.9% | 26,700 |
| 2024/05/21 | 3,465 | 3,485 | 3,420 | 3,420 | -40 | -1.2% | 29,300 |
| 2024/05/20 | 3,445 | 3,465 | 3,445 | 3,460 | +20 | +0.6% | 56,700 |
| 2024/05/17 | 3,435 | 3,460 | 3,430 | 3,440 | -5 | -0.1% | 31,300 |
| 2024/05/16 | 3,425 | 3,445 | 3,415 | 3,445 | +20 | +0.6% | 26,500 |
| 2024/05/15 | 3,450 | 3,450 | 3,420 | 3,425 | -25 | -0.7% | 23,300 |
| 2024/05/14 | 3,465 | 3,470 | 3,425 | 3,450 | -15 | -0.4% | 34,200 |
| 2024/05/13 | 3,450 | 3,515 | 3,435 | 3,465 | +45 | +1.3% | 102,100 |
| 2024/05/10 | 3,325 | 3,470 | 3,270 | 3,420 | +115 | +3.5% | 173,600 |
| 2024/05/09 | 3,345 | 3,345 | 3,295 | 3,305 | -40 | -1.2% | 41,100 |
| 2024/05/08 | 3,350 | 3,380 | 3,345 | 3,345 | -20 | -0.6% | 24,400 |
| 2024/05/07 | 3,370 | 3,385 | 3,350 | 3,365 | +5 | +0.1% | 16,500 |
| 2024/05/02 | 3,355 | 3,375 | 3,335 | 3,360 | +5 | +0.1% | 14,800 |
| 2024/05/01 | 3,320 | 3,360 | 3,320 | 3,355 | +25 | +0.8% | 20,100 |
| 2024/04/30 | 3,330 | 3,330 | 3,310 | 3,330 | +25 | +0.8% | 7,300 |
| 2024/04/26 | 3,305 | 3,325 | 3,270 | 3,305 | -15 | -0.5% | 28,700 |
101～
150
件表示中 / 2191件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 156,900円 | -5.1% | -21.2% | 5.10% | 9.91倍 | 1.89倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ハートシード | 150,300円 | +154.1% | - | 0.00% | - | 7.36倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ダイト | 212,900円 | +4.5% | -10.8% | 3.29% | 14.16倍 | 0.63倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| 扶桑薬 | 255,500円 | +8.3% | +98.1% | 3.21% | 8.39倍 | 0.58倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| セルソース | 102,500円 | -3.0% | -55.9% | 0.49% | 48.69倍 | 3.36倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
